Categories: HealthcareNews

IntoValue, Inc Welcomes Brian Marcotte to Board of Directors

IntoValue, Inc, proudly announces the appointment of Brian Marcotte to its Board of Directors.

WASHINGTON, DC / ACCESSWIRE / July 29, 2024 / IntoValue, Inc, a groundbreaking healthcare direct-to-employer technology enablement company, proudly announces the appointment of Brian Marcotte to its Board of Directors.

IntoValue
logo for IntoValue

Brian Marcotte brings a wealth of executive leadership experience to IntoValue, having served as President and CEO of the Business Group on Health (BGH), a prominent advocacy group representing large, self-insured employers. During his tenure at BGH, Brian spearheaded initiatives such as the Health Innovations Forum and the Executive Committee on Value Purchasing, dedicated to scaling value-based care initiatives. Prior to his role at BGH, Brian held the position of Vice President of Compensation and Benefits at Honeywell International, where his innovative approach to employee healthcare garnered widespread recognition.

Dr. Marion Couch, CEO of IntoValue, expressed gratitude for Brian’s appointment, stating, “It is an honor to welcome Brian Marcotte to our Board, given his distinguished career at both Honeywell International and as the former President and CEO of the Business Group on Health. His profound understanding of the importance of healthcare improvement for employees, coupled with his thought leadership, will be invaluable assets to IntoValue.”

Brian Marcotte shared his enthusiasm for joining IntoValue, stating, “We cannot change health care if we do not change how it’s financed and paid for. Health care is local and preparing health systems and providers to transition away from fee-for-service to provide employers with accountable, value-based delivery alternatives is crucial to creating improved outcomes for employees. The success of such partnerships is evident, and the time is ripe to scale more community-based, direct-to-employer collaborations. I am thrilled to contribute to IntoValue’s mission as a Board member.”

About IntoValue, Inc:

IntoValue, Inc, headquartered in Washington, DC, is a pioneering technology-enabled direct-to-employer enablement company. Committed to revolutionizing healthcare delivery, IntoValue partners directly with self-insured employers and health systems. The company’s mission is to provide the data and technology resources to support health systems and providers to transition to value-based models, fostering improved employee health and community wellness. IntoValue empowers providers with a cutting-edge data analytics platform featuring predictive AI capabilities and it fosters equitable data sharing between employers and providers.

For media inquiries or further information, please contact:

www.intovaluegroup.com

Contact Information

Marion Couch
CEO
marion.couch@intovaluegroup.com
317-450-9119

SOURCE: IntoValue, Inc

View the original press release on newswire.com.

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

22 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

22 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

22 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

22 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

22 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

22 hours ago